Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

Letaxaban

Known as: 2(1H)-Pyrimidinone, 1-(1-((2S)-3-((6-chloro-2-naphthalenyl)sulfonyl)-2-hydroxy-1- oxopropyl)-4-piperidinyl)tetrahydro- 
An orally active, tetrahydropyrimidin-2(1H)-one derivative and inhibitor of coagulation factor Xa (activated factor X) with anticoagulant activity… Expand
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
Anticoagulant drugs comprise a specific subcategory of antithrombotic agents that act to inhibit blood coagulation at various… Expand
Is this relevant?
2017
2017
Introduction Le schema posologique des nouveaux anticoagulants oraux directs (AOD) differe entre les molecules (une ou deux… Expand
Is this relevant?
2016
2016
The geometries and energies of factor Xa inhibitors edoxaban, eribaxaban, fidexaban, darexaban, letaxaban, and the dual factor Xa… Expand
  • figure 1
  • table 1
  • table 1
  • table 2
  • figure 2
Is this relevant?
Review
2013
Review
2013
After the introduction of warfarin, long-term oral anticoagulation treatment remained unchanged for more than 50 years. Most… Expand
  • figure 1
  • figure 2
  • table 4
Is this relevant?
Review
2013
Review
2013
  • G. Denas, V. Pengo
  • Expert opinion on investigational drugs
  • 2013
  • Corpus ID: 12192857
Introduction: The introduction of novel anticoagulants has had contrasting effects on the agents in the pipeline, fueling the… Expand
Is this relevant?
Review
2012
Review
2012
Following the clinical approval of novel oral anticoagulants as alternatives to the vitamin K antagonists, many additional novel… Expand
Is this relevant?